A biotechnology company focused on developing products to address areas of major unmet need.
Topas Therapeutics has raised €40M across 2 funding rounds from 8 investors, most recently a Series B round in Jul 2021. Based in Hamburg, Germany; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-07-29 | Series B | €18M | BioMedPartners,Boehringer Ingelheim Venture Fund,EMBL Ventures,Epidarex Capital,Evotec,Gimv+1 more | View deal → |
| 2020-10-19 | Series B | €22M | BioMedPartners,Vesalius Biocapital Partners | View deal → |
